COLLEDAN, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 11.014
EU - Europa 9.112
AS - Asia 7.674
SA - Sud America 716
AF - Africa 97
Continente sconosciuto - Info sul continente non disponibili 24
OC - Oceania 15
Totale 28.652
Nazione #
US - Stati Uniti d'America 10.802
HK - Hong Kong 3.263
SG - Singapore 2.995
RU - Federazione Russa 2.551
IE - Irlanda 1.645
IT - Italia 1.444
DE - Germania 1.037
SE - Svezia 1.005
BR - Brasile 630
CN - Cina 599
GB - Regno Unito 321
UA - Ucraina 281
VN - Vietnam 228
FR - Francia 202
CA - Canada 167
IN - India 117
FI - Finlandia 114
NL - Olanda 98
ID - Indonesia 92
ES - Italia 85
KR - Corea 75
AT - Austria 71
BE - Belgio 55
BD - Bangladesh 48
TR - Turchia 47
CH - Svizzera 46
DK - Danimarca 42
IQ - Iraq 39
ZA - Sudafrica 32
AR - Argentina 26
SA - Arabia Saudita 26
EU - Europa 23
JP - Giappone 23
CZ - Repubblica Ceca 22
MX - Messico 20
PL - Polonia 20
PT - Portogallo 20
EC - Ecuador 18
EG - Egitto 17
UZ - Uzbekistan 14
KE - Kenya 13
PK - Pakistan 13
VE - Venezuela 13
IR - Iran 12
AU - Australia 11
RO - Romania 11
CO - Colombia 10
JO - Giordania 9
NP - Nepal 9
AE - Emirati Arabi Uniti 7
JM - Giamaica 7
LT - Lituania 7
MA - Marocco 7
PS - Palestinian Territory 7
RS - Serbia 7
AZ - Azerbaigian 6
TW - Taiwan 6
CL - Cile 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
GR - Grecia 5
IL - Israele 5
KZ - Kazakistan 5
PE - Perù 5
PH - Filippine 5
TN - Tunisia 5
BG - Bulgaria 4
MU - Mauritius 4
NZ - Nuova Zelanda 4
OM - Oman 4
PY - Paraguay 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AL - Albania 3
BH - Bahrain 3
ET - Etiopia 3
KG - Kirghizistan 3
LB - Libano 3
LV - Lettonia 3
ZW - Zimbabwe 3
EE - Estonia 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
KH - Cambogia 2
LU - Lussemburgo 2
LY - Libia 2
NI - Nicaragua 2
QA - Qatar 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 28.644
Città #
Hong Kong 3.253
Singapore 1.852
Dublin 1.603
Ann Arbor 1.253
Princeton 817
Fairfield 659
New York 658
Frankfurt am Main 591
Chandler 586
Ashburn 558
Woodbridge 527
Santa Clara 488
Houston 402
Lawrence 385
Wilmington 342
Altamura 338
Moscow 295
Seattle 257
Milan 252
Cambridge 207
Jacksonville 187
San Diego 141
Andover 117
Dearborn 111
Shanghai 102
Toronto 95
Jakarta 89
Rome 84
Hefei 78
Nuremberg 76
Munich 73
Beijing 68
London 62
Seoul 62
Nanjing 59
Ho Chi Minh City 57
Helsinki 52
Hanoi 47
Hangzhou 46
Los Angeles 44
Boardman 42
Chicago 42
São Paulo 41
Norwalk 34
Brussels 32
Guangzhou 32
Lachine 30
Rio de Janeiro 29
Boston 28
Vienna 28
Council Bluffs 27
Pune 25
Atlanta 24
Turin 23
Shenyang 22
Columbus 21
Esslingen am Neckar 21
Falls Church 21
Kilburn 21
Fremont 20
Turku 20
Belo Horizonte 19
Bergamo 19
Dallas 19
Dong Ket 18
Florence 17
Siena 17
Barcelona 16
Bologna 16
Brasília 16
The Dalles 16
Zurich 16
Amsterdam 15
Brooklyn 15
Naples 15
Ottawa 15
Tianjin 15
Utrecht 15
Riyadh 14
San Francisco 14
Tashkent 14
Valencia 14
Washington 14
Bari 13
Manchester 13
Philadelphia 13
San Mateo 13
Erbil 12
Lappeenranta 12
Miami 12
Padova 12
Baghdad 11
Cleveland 11
Curitiba 11
Genoa 11
Istanbul 11
Lisbon 11
Madrid 11
Paris 11
Redmond 11
Totale 18.104
Nome #
A multicentre outcome analysis to define global benchmarks for donation after circulatory death liver transplantation 537
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 343
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score 284
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 275
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy 271
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 228
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 217
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 216
Health related quality of life in chronic liver diseases 212
HCC persistence or recurrence after bridging therapy helps predict transplant list dropout and generate a more equitable exception policy 211
Reno-portal bypass for non tumorous portal vein thrombosis in adult liver transplantation 211
Health Related Quality of Life in the Major Liver Conditions 206
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 205
Delaying surgery for patients with a previous SARS-CoV-2 infection 198
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 197
Preliminary Analysis of the Impact of COVID-19 Outbreak on Italian Liver Transplant Programs 195
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 191
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 190
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis 186
Balancing donor and recipient risk factors in liver transplantation: The value of D-MELD with particular reference to HCV recipients 183
Multicentre evaluation of case volume in minimally invasive hepatectomy 180
The impact of the COVID-19 outbreak on Liver Transplantation programmes in Northern Italy 180
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling 176
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list 174
Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry 172
Treatment of hepatocellular carcinoma: A cost analysis of yttrium-90 transarterial radioembolization versus sorafenib 170
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 169
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 168
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 167
Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria 161
Trapianto intestinale 158
Combined double lung-liver transplantation for cystic fibrosis without cardio-pulmonary by-pass. 157
COVID-19: role of resilience on the psychological impact of lockdown in liver transplant transitional candidates and recipients COVID-19: ruolo della resilienza sull’impatto psicologico del lockdown nei candidati e nei riceventi del trapianto di fegato (adolescenti-giovani adulti) 155
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ovarian and gastrointestinal peritoneal carcinomatosis: Results from a 7-year experience 153
Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobulinemia in a liver/kidney transplant recipient 151
Nuclear expression of s100a4 calcium binding protein increases cholangiocarcinoma invasiveness and metastasization 149
Early detection of the graft failure after pediatric liver transplantation: a Bergamo experience 148
Extended right split liver graft for primary transplantation in children and adults. 145
Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 144
Successful pre- and posttransplant sofosbuvir-based anti-hepatitis C virus treatment in persons living with human immunodeficiency virus infection 144
Experience with the use of basiliximab in liver transplantation--use in pediatric and adult recipients in combination with cyclosporine or tacrolimus 140
Covid-19 and gender: lower rate but same mortality of severe disease in women-an observational study 140
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study 139
Full-right-full-left split liver transplantation: The retrospective analysis of an early multicenter experience including graft sharing 137
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 137
Very Early Introduction of Everolimus in De Novo Liver Transplantation: Results of a Multicenter, Prospective, Randomized Trial 135
Post-operative heparin reduces early venous thrombotic complications after orthotopic paediatric liver transplantation 135
Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma 134
Is minimally invasive liver surgery a reasonable option in recurrent HCC? A snapshot from the I Go MILS registry 134
Use of extended right grafts from in situ split livers in adult liver transplantation: a comparison with whole-liver transplants. 130
A prospective policy development to increase split-liver transplantation for 2 adult recipients: Results of a 12-year multicenter collaborative study 128
Correction to: Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry (Updates in Surgery, (2017), 69, 3, (271-283), 10.1007/s13304-017-0489-x) 127
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 124
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using “on demand” Approach: A Single Center Experience 121
Selective use of ex-situ machine perfusion after normothermic regional perfusion in liver transplantation from donation after circulatory death 121
Biliary complications in pediatric liver transplantation: findings of percutaneous transhepatic cholangiography in a large single-center cohort 121
Early post-liver transplant surgical morbidity in HIV-infected recipients: risk factor for overall survival? A nationwide retrospective study 118
Favorable outcome of primary liver transplantation in children with cirrhosis and hepatocellular carcinoma 113
A matched pair analysis of multicenter longterm follow-up after split-liver transplantation with extended right grafts 111
Physiological reno-portal bypass in liver transplantation with non-tumorous portal vein thrombosis 103
null 102
The Role of Imaging in Portal Vein Thrombosis: From the Diagnosis to the Interventional Radiological Management 100
A national mandatory-split liver policy: A report from the Italian experience 100
Vaccination Recommendations in Solid Organ Transplant Adult Candidates and Recipients 99
The Activity of the Liver-Transplant Center of Milan, Italy 99
Location and allocation: inequity of access to liver transplantation for patients with severe acute‐on‐chronic liver failure in Europe 99
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using" on demand" Approach: A Single Center Experience 98
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic 97
Liver transplantation in patients with B viral hepatitis and delta infection 97
Results of 24 orthotopic liver transplantation in Milan 96
Arterioportal fistulas (Apfs) in pediatric patients: Single center experience with interventional radiological versus conservative management and clinical outcomes 94
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 92
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation 92
Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study: Are these still extended criteria liver grafts? 90
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study 90
Liver Perfusion in Multiorgan Harvesting for Transplantation 90
Evidence for biliary epithelial to mesenchymal transition in human cholangiocarcinoma 90
Extended criteria liver donation after circulatory death with prolonged warm ischemia: a pilot experience of normothermic regional perfusion and no subsequent ex-situ machine perfusion 89
Venous outflow obstruction in pediatric left lateral segment split liver transplantation 88
Current Endovascular Management of Arterial Complications After Pediatric Liver Transplantation in a Tertiary Center 87
Portal vein thrombosis and liver transplantation: management, matching, and outcomes: a retrospective multicenter cohort study 86
LIVER COLD-STORAGE USING UW SOLUTION - CLINICAL-RESULTS IN 23 CONSECUTIVE TRANSPLANTS 86
Organ Procurement for Multivisceral Abdominal Transplantation in the Pig 86
AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool 85
HEPATITIS-C VIRUS-INFECTION AND LIVER-TRANSPLANTATION 85
Back-Table Surgery for Liver Grafts 84
Pediatric liver transplantation: Indications, risk factors, and results 84
D-MELD, a Powerful Instrument To Optimize Donor-2-Recipient Match. Differences between US and Italy 84
B-Hepatitis and Liver-Transplantation 83
Long-term results after liver transplantation in B and delta hepatitis 83
EVIDENCE FOR EPITHELIAL-MESENCHYMAL TRANSITION IN HUMAN CHOLANGIOCARCINOMA 80
Patterns of hepatitis delta virus reinfection and disease in liver transplantation 79
Liver transplants in children: The 8 years experience in Bergamo 79
BENCH RECONSTRUCTION OF THE GRAFT ARTERIAL SUPPLY IN LIVER-TRANSPLANTATION 78
Induction of class I and class II major histocompatibility complex antigens (MHC) in rejecting human liver grafts 78
Liver transplantation for hepatocellular carcinoma: Bergamo experience 78
Correction to: Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group (Hepatology International, (2020), 14, 6, (930-943), 10.1007/s12072-020-10091-5) 78
Full-Left Full-Right Split Liver Transplantation 77
DOES THE EXPERIENCE WITH LIVER-TRANSPLANTATION SUGGEST THAT HEPATITIS-DELTA VIRUS IS NOT CYTOPATHIC 77
Improving outcomes of in situ split liver transplantation in Italy over the last 25 years 76
Totale 14.040
Categoria #
all - tutte 169.574
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 169.574


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.476 69 59 137 141 137 135 167 138 144 127 94 128
2021/20223.535 67 81 172 585 183 192 63 206 90 969 155 772
2022/20234.576 815 1.320 379 209 212 860 54 183 248 84 148 64
2023/20244.548 76 98 164 160 682 1.142 894 139 549 66 78 500
2024/202511.943 647 1.854 488 490 1.059 272 500 338 1.693 1.843 923 1.836
2025/20261.083 1.083 0 0 0 0 0 0 0 0 0 0 0
Totale 30.094